Nobivac^® Tricat Trio Questions and Answers

Active immunisation of cats:

• To reduce the clinical signs caused by infection with feline calicivirus (FCV) and feline herpes virus type 1 (FHV)
• To prevent the clinical signs, leucopenia and virus excretion caused by infection with feline panleucopenia virus (FPLV)

The onset of immunity as demonstrated by challenge is 4 weeks for feline calicivirus and feline herpesvirus and 3 weeks for feline panleucopaenia virus.

The minimum duration of immunity has been determined to be 1 year for feline calicivirus and herpesvirus and 3 years for feline panleucopaenia virus.

Do not use during pregnancy or lactation, as the product has not been tested in pregnant or lactating queens. Live FPL virus can cause reproductive problems in pregnant queens and birth defects in the progeny.

We do not hold specific data regarding use during lactation and therefore cannot recommend this use during this period.

Nobivac Tricat Trio requires storage in a refrigerator between 2 ^oC and 8 ^oC. Protect from light.

There are no breed specific contraindications for Nobivac Tricat Trio.

The SPC and Datasheet for Nobivac Tricat Trio reads as follows:

‘No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.’

Yes, as the combined use of Nobivac Tricat Trio and Nobivac FeLV is described on the Nobivac FeLV datasheet and SPC:

"Safety and efficacy data are available which demonstrate that this vaccines can be mixed and administered with cat vaccines of the Nobivac range containing feline calicivirus (F9 strain), feline rhinotracheitis virus (G2620A strain) and/or feline panleucopenia virus (MW-1 or Bristol strain)." 

Two single dose inoculations, 3-4 weeks apart. The first inoculation can be given from the age of 8-9 weeks and the second inoculation from the age of 12 weeks.

See also section “Special warnings for each target species" on the product datasheet.

A single dose (1 ml) according to the following schedule:

• Revaccination against feline calicivirus and feline herpesvirus type 1 must be given every year (with vaccines containing the F9 and G2620 strains, where available)
• Revaccination against feline panleucopenia virus can be given every three years (with strain MW-1 as in Nobivac Tricat Trio, where available)

To reconstitute freeze dried small animal Nobivac vaccines which include instructions to be reconstituted with Nobivac Solvent.

Nobivac Solvent requires storage not exceeding 25 °C and protected from light. Do not freeze.

Shelf life of the veterinary medicinal product as packaged for sale: 2 years

* Nobivac FeLV is presented as a suspension for injection therefore does not require reconsitution.

Each vaccine is formulated on the basis of a minimum immunising dose, not a dose per body weight. Therefore the full vaccine dose/reconstituted amount is the minimal immunising dose.

In order for the product shelf-life to be as it is stated on the product's SPC it should be stored as per the datasheet's storage requirements. This will always be our recommendation for product use.

In the case of any doubt it would be advisable to contact the Technical Product Support team before discarding any product.

In the event where it is advisable to discard product it may be possible to claim on the practice's insurance. Our Technical Product Support team can write a letter of support for insurance claims, pertaining to deviations in storage conditions, should you require it.